SNP Genotyping for Nucleic Acid Quality Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for assessing genomic DNA quality in biorepositories lack standardization, failing to provide comprehensive information on gender, ethnicity, and sample uniqueness, which are crucial for ensuring the integrity and quality of nucleic acid samples for downstream applications.
Innovation Solution
A collection of genetic markers, including single nucleotide polymorphisms (SNPs), is used to assess the quality and integrity of nucleic acid samples by genotyping for specific markers, with the results stored on a computer-readable medium and analyzed using a database to determine gender, ethnicity, and uniqueness, ensuring high-quality sample management.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If non-specific assays are used to assess gDNA quality, then global quality measurement is achieved, but information on gender mismatches, sample contamination, and ethnicity is lost
Solution Approach 1:
The patent segments the quality assessment into multiple specific genetic marker analyses (gender markers, ethnicity markers, contamination markers) rather than using a single non-specific assay. Each marker type addresses a specific information need, allowing comprehensive quality assessment while preserving detailed sample characteristics.
Solution Approach 2:
The patent creates a universal SNP genotyping platform that simultaneously performs multiple functions: gender determination, ethnicity identification, contamination detection, and overall quality assessment. This multi-functional approach eliminates information loss while maintaining comprehensive quality measurement.
2Reliability
If standardized SNP genotyping methods are implemented, then sample quality and uniqueness assessment is improved, but processing time and computational requirements increase
Solution Approach 1:
The patent performs SNP genotyping and quality assessment early in the biorepository workflow, before samples are stored or used in downstream applications. This preliminary action ensures quality issues are identified early, preventing wasted time on poor-quality samples later in the process.
Solution Approach 2:
The patent uses digital data copying and database storage of SNP genotyping results, allowing rapid retrieval and comparison of sample characteristics without requiring physical re-analysis. This reduces processing time for quality verification while maintaining reliability.
3Measurement precision
If comprehensive genetic marker analysis is performed, then sample characterization accuracy is improved, but cost and complexity of the assay increase
Solution Approach 1:
The patent employs a universal SNP genotyping assay platform that can simultaneously analyze multiple genetic markers for different purposes (gender, ethnicity, contamination, uniqueness). This multi-functional approach achieves comprehensive sample characterization while avoiding the need for multiple separate complex assays.
Solution Approach 2:
The patent optimizes the SNP marker panel to include a specific number and type of markers that provide maximum characterization accuracy with minimum assay complexity. By carefully selecting and weighting different marker types, the assay achieves high precision without excessive complexity.
Data Source
AI summary
Methods for improved quality control of nucleic acid containing biological samples utilized in high-throughput situations such as biorepositories engaged in the collection, processing, storage, distribution and analysis of such samples are disclosed.